The Latest Cardiac and Vascular News
Authors: Denis Roy1, Suzanne Romano2, Jay W. Mason3, Monica Wynn2, Charles Pollack4, Gary Elliot5, Mireille Gillings2, Jerome B. Riebman2 SAN DIEGO, April 24, 2025 /PRNewswire/ — HUYABIO International today announced the presentation of new patient data for HBI-3000, a novel bioinspired…
ew investment fuels growth of ECG-AI platform and development of perioperative AI capabilities CAMBRIDGE, Mass.–(BUSINESS WIRE)–Anumana, a leading AI-driven health technology company, has expanded beyond its diagnostic ECG-AI™ technology into perioperative and acute cardiac care. The company recently brought on Boston Scientific Corporation as a new investor in its Series […]
Published in the International Journal of Cardiology, new study demonstrates 91.6% accuracy and introduces the HF-index for on-demand severity tracking TOKYO, April 24, 2025 /PRNewswire/ — Simplex Quantum, in collaboration with the University of Tokyo Hospital, today announced the…
Comprehensive analysis of real-world data shows significant clinical and medico-economic advantages of Implicity’s universal, alert-based remote monitoring platform CAMBRIDGE, Mass., April 24, 2025 /PRNewswire/ — IMPLICITY®, a leader in remote patient monitoring and cardiac data…
– Intellisense AFib Technology Able to Detect Possible Atrial Fibrillation with Every Measurement; May 17 Marks World Hypertension Day during May Measurement Month – KYOTO, Japan, April 24, 2025 /PRNewswire/ — OMRON Healthcare Co., Ltd. (Head Office: Muko, Kyoto Prefecture; hereinafter…
Budiodarone shown in Phase 2 to reduce atrial fibrillation symptoms and long episodes of atrial fibrillation (LEAF) FDA gives guidance on steps necessary to gain approval and incorporate wearable AF monitoring devices into label for budiodarone Five granted US patents align with FDA’s…
ST. LOUIS, April 21, 2025 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, announced today it will host a live demonstration of the GenesisX Robotic System at this year’s Heart Rhythm Symposium (HRS), taking place April 24 – 27 […]
Advancing PFA through a science-led, portfolio-driven approach to innovation MARLBOROUGH, Mass.–(BUSINESS WIRE)–CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for cardiac arrhythmias, is excited to announce its featured presence at Heart Rhythm 2025 in San Diego, where the company will showcase the latest advancements and clinical progress […]
Nanosecond PFA 360° Cardiac Catheter for AF ablation to be highlighted in presentations and in a live case transmission HAYWARD, Calif.–(BUSINESS WIRE)–Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) technology, today announced that its Nanosecond PFA technology will […]
MINNEAPOLIS–(BUSINESS WIRE)–Imricor Medical Systems, Inc. (Company or Imricor) (ASX: IMR) is pleased to announce that it has commenced the VISABL-VT clinical trial by completing the first-in-human ventricular ablation guided by real-time MRI with the Company’s NorthStar Mapping System. The procedure was performed by the team at the Amsterdam University Medical Centre (AUMC), ranked […]
